Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ADGM

Adagio Medical Holdings Inc

Apr 20 • 04:00PM ET

1.53

-0.02 -1.29 %

Healthcare • Medical Devices • USA • NASD

Apr 14, 12:01 PMPiper Sandler overweight initiation and $3 target ignite ADGM's 20% surge.

Peers: BSX STXS EW LXRX NVRO CUTR BLFS CLPT

| Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.67	Insider Own	2.13%	Shs Outstand	22.21M	Perf Week	15.04%
Market Cap	33.98M	Forward P/E	-	EPS next Y	-1.70	Insider Trans	88.64%	Shs Float	21.74M	Perf Month	48.54%
Enterprise Value	38.63M	PEG	-	EPS next Q	-0.29	Inst Own	74.61%	Short Float	0.11%	Perf Quarter	68.13%
Income	-25.08M	P/S	-	EPS this Y	16.23%	Inst Trans	9.63%	Short Ratio	0.25	Perf Half Y	3.38%
Sales	0.00M	P/B	2.74	EPS next Y	-33.99%	ROA	-52.57%	Short Interest	0.02M	Perf YTD	47.12%
Book/sh	0.56	P/C	1.99	EPS next 5Y	-11.18%	ROE	-155.25%	52W High	2.58 -40.74%	Perf Year	-14.04%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	63.65% -364.47%	ROIC	-73.77%	52W Low	0.74 106.76%	Perf 3Y	-85.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	13.27% 10.91%	Perf 5Y	-85.87%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	92.41%	Oper. Margin	-	ATR (14)	0.14	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.24	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	62.48	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.44	EPS Q/Q	95.65%	SMA20	16.75%	Beta	0.25	Target Price	3.50
Payout	-	Debt/Eq	1.75	Sales Q/Q	-100.00%	SMA50	35.60%	Rel Volume	0.35	Prev Close	1.55
Employees	41	LT Debt/Eq	1.74	Earnings	Mar 27 BMO	SMA200	21.41%	Avg Volume	96.79K	Price	1.53
IPO	Feb 26, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	32.26% -	Trades		Volume	34,113	Change	-1.29%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-14-26	Initiated	Piper Sandler	Overweight	$3
Dec-02-25	Initiated	Lake Street	Buy	$4

Apr-16-26 08:00AM	Adagio Medicals ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference (Business Wire)
Apr-06-26 08:00AM	Adagio Medical to Participate in the 25th Annual Needham Virtual Conference (Business Wire)
Apr-01-26 08:00AM	Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026 (Business Wire)
Mar-27-26 08:00AM	Adagio Medical Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Mar-24-26 08:00AM	Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter (Business Wire) +11.50%
08:00AM	Loading…
Mar-19-26 08:00AM	Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS System, Including Patients with Premature Ventricular Contractions (PVC) (Business Wire)
Mar-11-26 08:00AM	Adagio Medical to Participate in the 38th Annual Roth Conference (Business Wire)
Feb-24-26 01:11PM	Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study (Insider Monkey)
Feb-20-26 08:00AM	Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference (Business Wire)
Feb-04-26 08:00AM	New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia (Business Wire)
Feb-02-26 08:05AM	Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
Dec-22-25 08:00AM	Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness (Business Wire) +5.83%
Dec-11-25 08:00AM	Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors (Business Wire)
Nov-12-25 04:05PM	Adagio Medical Reports Third Quarter 2025 Results (Business Wire)
Oct-20-25 08:00AM	Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia (Business Wire) +5.45%
08:00AM	Loading…
Oct-15-25 08:00AM	Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities (Business Wire) -19.88%
Oct-10-25 03:40PM	Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium (Business Wire) -13.93%
Oct-01-25 08:00AM	Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia (Business Wire)
Sep-18-25 08:00AM	Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium (Business Wire) +11.66%
Sep-08-25 08:00AM	Adagio Medical Expands Chief Business Officer Deborah Kasters Role to Include Chief Financial Officer Responsibilities (Business Wire) -12.03%
Aug-13-25 04:30PM	Adagio Medical Reports Second Quarter 2025 Results (Business Wire)
May-15-25 04:05PM	Adagio Medical Reports First Quarter 2025 Results (Business Wire)
May-07-25 08:30AM	Adagio Medical to Present at the BofA Securities 2025 Health Care Conference (Business Wire)
Apr-17-25 08:30AM	Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System (Business Wire) +92.81%
Mar-31-25 04:01PM	Adagio Medical Appoints Deborah Kaster as Chief Business Officer (Business Wire) -14.36%
08:30AM	Adagio Medical Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Mar-17-25 04:01PM	Adagio Medical Provides Clinical and Business Updates (Business Wire) -7.41% -9.00%
Feb-28-25 08:30AM	Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation (Business Wire) -45.94%
Feb-18-25 04:01PM	Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference (Business Wire)
Dec-16-24 08:00AM	Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director (Business Wire) -9.41%
04:01PM	Loading…
Nov-14-24 04:01PM	Adagio Medical Reports Third Quarter 2024 Results (Business Wire) +57.87% -19.14%
Nov-04-24 04:01PM	Adagio Medical to Present at the Stifel 2024 Healthcare Conference (Business Wire) +7.75%
Oct-24-24 08:30AM	Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System (Business Wire)
Oct-07-24 04:01PM	Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias (Business Wire) -7.14%
Aug-19-24 04:01PM	Adagio Medical Provides Business Updates (Business Wire)

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kaster Deborah	Chief Financial Officer	Dec 16 '25	Buy	1.20	15,000	17,973	15,000	Dec 18 06:00 AM
Usen Todd	Chief Executive Officer	Dec 12 '25	Buy	1.09	207,315	225,973	207,315	Dec 15 09:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADGM

Adagio Medical Holdings Inc

Upgrade your Finviz experience